AA
CVS icon

Advisory Alpha’s CVS Health CVS Stock Holding History

Advisory Alpha’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$752K Buy
7,273
+687
+10% +$61.3K 0.02% 274
2026
Q1 		$473K Buy
6,586
+1,241
+23% +$95.6K 0.01% 339
2025
Q4 		$424K Buy
5,345
+277
+5% +$21.8K 0.01% 336
2025
Q3 		$393K Buy
5,068
+600
+13% +$41.1K 0.01% 346
2025
Q2 		$308K Buy
4,468
+78
+2% +$5.12K 0.01% 359
2025
Q1 		$297K Buy
+4,390
New +$263K 0.01% 350
2024
Q4 		– Sell
-3,277
Closed -$206K – 439
2024
Q3 		$206K Sell
3,277
-472
-13% -$27.5K 0.01% 405
2024
Q2 		$221K Sell
3,749
-4
-0.1% -$250 0.01% 354
2024
Q1 		$299K Buy
3,753
+329
+10% +$25.1K 0.01% 298
2023
Q4 		$270K Sell
3,424
-250
-7% -$17.8K 0.01% 281
2023
Q3 		$257K Buy
3,674
+606
+20% +$42.9K 0.01% 258
2023
Q2 		$212K Sell
3,068
-295
-9% -$21K 0.01% 305
2023
Q1 		$250K Buy
3,363
+666
+25% +$55.8K 0.02% 244
2022
Q4 		$251K Sell
2,697
-1,237
-31% -$119K 0.02% 227
2022
Q3 		$375K Buy
3,934
+74
+2% +$7.33K 0.03% 181
2022
Q2 		$358K Buy
3,860
+1,285
+50% +$125K 0.03% 185
2022
Q1 		$261K Buy
+2,575
New +$271K 0.02% 229
2020
Q4 		– Sell
-806
Closed -$48K – 215
2020
Q3 		$48K Buy
+806
New +$50.2K 0.01% 211
2020
Q2 		– Sell
-799
Closed -$49K – 189
2020
Q1 		$49K Buy
799
+161
+25% +$10.7K 0.01% 209
2019
Q4 		$46.4K Buy
638
+331
+108% +$23.2K 0.01% 288
2019
Q3 		$18.7K Buy
+307
New +$18.2K 0.01% 376
2019
Q2 		– Sell
-268
Closed -$14.8K – 222
2019
Q1 		$14.8K Buy
+268
New +$16.5K 0.01% 364

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Advisory Alpha's CVS Position: Q2 2026 in Review

Advisory Alpha increased its CVS Health (CVS) stake by 10% in Q2 2026, buying an estimated $61.3K and bringing the position to 7,273 shares worth $752K. The position accounts for 0.02% of the portfolio, ranked #274.

Advisory Alpha first reported a position in CVS in Q1 2019 and has held it in 22 quarters since. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Advisory Alpha held 7,273 shares of CVS Health worth $752K as of Q2 2026.
  • Advisory Alpha bought 687 CVS Health shares in Q2 2026, an estimated $61.3K.
  • CVS Health made up 0.02% of Advisory Alpha's portfolio in Q2 2026, its #274 holding.
  • Advisory Alpha first reported a position in CVS Health in Q1 2019 and has held it in 22 quarters since.
  • 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Advisory Alpha's 13F filing for Q2 2026, filed 11 Aug 2026.